Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 6/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 7/20 | 0.42 |
| ▸ | CA2 | P00918 | 7/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 2/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LATS1 | O95835 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14667071 | 0.89 | MALT1 (0.47) | MALT1CA12CA9CA4CA7 | |
| SCHEMBL22461476 | 0.84 | NAMPT (0.46) | BRD4 | |
| SCHEMBL22461371 | 0.84 | CA7 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL14667072 | 0.83 | MALT1 (0.43) | MALT1CA12CA9CA4CA7 | |
| SCHEMBL6128009 | 0.83 | CA12 (0.63) | CA12CA9CA4CA7CA14 | |
| SCHEMBL1514682 | 0.82 | BCHE (0.48) | MALT1BCHE | |
| SCHEMBL134374 | 0.82 | CA12 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL12041802 | 0.82 | TTR (0.44) | CA12CA9CA4CA7CA14 | |
| SCHEMBL21347989 | 0.81 | CA12 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL21347987 | 0.81 | CA12 (0.47) | CA12CA9CA4CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1802710-B1 | METHODS FOR FORMING DYED MICROSPHERES AND POPULATIONS OF DYED MICROSPHERES | LUMINEX CORP (US) | 2016-02-24 | — | — | EP | disclosed |
| EP-2559738-B1 | Methods for forming dyed microspheres and populations of dyed microspheres | LUMINEX CORP (US) | 2014-07-09 | — | — | EP | disclosed |
| EP-2559738-A1 | Methods for forming dyed microspheres and populations of dyed microspheres | Luminex Corporation (US) | 2013-02-20 | — | — | EP | disclosed |
| US-8361169-B2 | Methods for forming dyed microspheres and populations of dyed microspheres | LUMINEX CORPORATION (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120035328-A1 | METHODS FOR FORMING DYED MICROSPHERES AND POPULATIONS OF DYED MICROSPHERES | HOFFACKER KURT D (US) | 2012-02-09 | — | — | US | disclosed |
| US-8038734-B2 | Methods for forming dyed microspheres and populations of dyed microspheres | LUMINEX CORPORATION (US) | 2011-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035328-A1 | METHODS FOR FORMING DYED MICROSPHERES AND POPULATIONS OF DYED MICROSPHERES | CD68, CD14, MYADM | MALT1 4703/4885CA12 1450/4885CA9 2052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.